The oncolytic virus immunotherapy market presents opportunities with three approved therapies, extensive clinical trial pipelines, and innovative research by biotechnology and pharmaceutical companies ...

Immunotherapy is a type of cancer treatment that uses the power of a person’s immune system to fight their cancer. Instead of directly attacking cancer cells like chemotherapy or radiation, ...

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible ...

At present, only around 5% of patients with colon cancer are candidates for immunotherapy. This new biomarker could make it possible to determine more accurately which individuals may receive this ...

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with limited curative options. Tumor vaccines ...

Immunotherapy has exhibited dramatic efficacy in clinical practices especially cancer, nevertheless, substantial clinical benefits of immunotherapy have only been achieved on a minority of patients, ...

In the discussion, Richard Goldberg, MD, a gastrointestinal oncologist at the WVU Cancer Institute, highlighted a fundamental ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...

Researchers showed that an experimental therapy indirectly converted suppressive immune cells into tumor-fighting cells. This ...